Affichage 1 à 2 des 2 essais cliniques
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Phase 3, Multicenter, Randomized, Double-Blind Study of MK-7684 With Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer
KEYVIBE-003 (MK-7684A-003) NCT05734105  Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Alina Lungescu 514-934-1934 |
|
|
(EN) A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Peak NCT05208047 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
Samara Bloom 514-252-3400 poste 6244 |
Groupe d'étude en oncologie du Québec